Mixed-matrix adsorption–diffusion membranes for lower-resource dialysis

A 2025-founded medtech venture developing mixed-matrix membranes that combine diffusion and adsorption in one dialyzer. The platform targets higher uremic-toxin clearance, lower dialysate consumption, and eventual wearable artificial-kidney applications. This is a particularly direct collaboration/licensing lead for Baxter: engage on hollow-fiber/module integration, hemocompatibility and albumin-retention testing, scale-up, and co-development of a next-generation dialyzer.